Motif Bio PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2015
2016
2017
2018
SG&A Expense
5,405.20
29,427.80
29,520.10
13,966.50
EBIT
5,405.20
29,427.80
29,520.10
13,966.50
Unusual Expense
3.30
39.00
4,963.10
4,990.20
Non Operating Income/Expense
6.30
186.00
185.00
30
Interest Expense
175.60
284.00
213.90
1,619.90
Pretax Income
5,574.00
29,885.10
34,778.40
10,481.40
Income Tax
0.50
0.20
17.10
6.80
Consolidated Net Income
5,574.50
29,885.40
34,795.50
10,488.20
Net Income
5,574.50
29,885.40
34,795.50
10,488.20
Net Income After Extraordinaries
5,574.50
29,885.40
34,795.50
10,488.20
Net Income Available to Common
5,574.50
29,885.40
34,795.50
10,488.20
EPS (Basic)
0.09
0.26
0.15
0.04
Basic Shares Outstanding
61,225.90
116,558.20
231,530.10
284,530.50
EPS (Diluted)
0.09
0.26
0.15
0.05
Diluted Shares Outstanding
61,225.90
116,558.20
231,530.10
287,131.70
EBITDA
5,405.20
29,427.80
29,520.10
13,966.50
Non-Operating Interest Income
9.80
51.70
103.80
84.70

About Motif Bio

View Profile
Address
5 Independence Way
Princeton New Jersey 08540
United States
Employees -
Website https://www.motifbio.com/
Updated 07/08/2019
Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi). The company was founded on November 20, 2014 and is headquartered in New York, NY.